Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors (Q33402421)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors |
scientific article |
Statements
1 reference
Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors (English)
1 reference
Toshihiko Doi
1 reference
Takayuki Yoshino
1 reference
Atsushi Ohtsu
1 reference
Narikazu Boku
1 reference
Kazuhiro Shibayama
1 reference
Takatoshi Takubo
1 reference
Haruyasu Murakami
1 reference
Nobuyuki Yamamoto
1 reference
Satoru Otani
1 reference
Elwyn Loh
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference